Skip to main content
. 2016 Nov 25;8(3):4875–4887. doi: 10.18632/oncotarget.13608

Table 1. Clinico-pathological characteristics of cohort.

Patients, n (%)
Age (<70/>70) 34 (37.0)/56 (60.9)
Gleason (<7/7/>7) 24 (26.1)/ 25 (27.2)/ 28 (30.4)
PSA at diagnosis (<10/10/>10) 19 (20.7)/ 14 (15.2)/ 36 (39.1)
Lymphovascular invasion (no/yes) 84 (91.3)/ 6 (6.5)
PSA at recurrence (<10/10/>10) 38 (41.3)/ 1 (1.1)/ 10 (10.9)
Ki67 (median/>median) 46 (50)/ 39 (42.4)

Number of patients with missing data is not displayed. Values that do not give a sum of 100% is due to data being unavailable.